Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance

Detalhes bibliográficos
Principais autores:	Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR
Formato:	Conference item
Idioma:	English
Publicado em:	Springer Nature 2019

Registros relacionados

Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
por: Xu, S, et al.
Publicado em: (2021)

Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
por: Wamil, M, et al.
Publicado em: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
por: Leal, J, et al.
Publicado em: (2022)

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
por: Holman, R, et al.
Publicado em: (2017)

Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
por: Currie, G, et al.
Publicado em: (2017)

Increased risk of incident heart failure and all-cause mortality in insulin-resistant people with type 2 diabetes in the United Kingdom Prospective Diabetes Study (UKPDS)
por: Wamil, M, et al.
Publicado em: (2020)

Comparison of medical resources and costs among patients with coronary heart disease and impaired glucose tolerance in the Acarbose Cardiovascular Evaluation trial
por: Liam Mc Morrow, et al.
Publicado em: (2024-02-01)

Prevalence of Impaired Fasting Glucose and Impaired Glucose Tolerance in Non-Diabetic Patients with Coronary Artery Disease
por: Nihar Ranjan Mohanty, et al.
Publicado em: (2022-06-01)

Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89
por: Wamil, M, et al.
Publicado em: (2021)

People at increased risk of cardiovascular disease screened for the NAVIGATOR trial frequently have undiagnosed diabetes or impaired glucose tolerance
por: Califf, R, et al.
Publicado em: (2003)

Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial.
por: Califf, R, et al.
Publicado em: (2008)

Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetes.
por: Anke Tönjes, et al.
Publicado em: (2010-01-01)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): a cohort analysis.
por: Yates, T, et al.
Publicado em: (2014)

Association between change in daily ambulatory activity and cardiovascular events in people with impaired glucose tolerance (NAVIGATOR trial): A cohort analysis
por: Yates, T, et al.
Publicado em: (2014)

Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
por: Gerstein, H, et al.
Publicado em: (2006)

Framingham risk equations underestimate coronary heart disease risk in diabetes.
por: Stevens, R, et al.
Publicado em: (2005)

Perceived Symptoms in People Living with Impaired Glucose Tolerance
por: Susanne Andersson, et al.
Publicado em: (2011-01-01)

Florid diabetic complications in impaired glucose tolerance
por: Anil P Bhatt, et al.
Publicado em: (2013-01-01)

Association between impaired glucose tolerance and circulating concentration of Lp(a) lipoprotein in relation to coronary heart disease.
por: Farrer, M, et al.
Publicado em: (1993)

Oxidative injury and neuropathy in diabetes and impaired glucose tolerance
por: James W. Russell, et al.
Publicado em: (2008-06-01)

Impaired Secretion of Total Glucagon-like Peptide-1 in People with Impaired Fasting Glucose Combined Impaired Glucose Tolerance
por: Fang Zhang, Xialian Tang, Hongyi Cao, Qingguo Lü, Nali Li, Yupu Liu, Xiangxun Zhang, Yuwei Zhang, Mingming Cao, Jun Wan, Zhenmei An, Nanwei Tong
Publicado em: (2012-01-01)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
por: Holman, R, et al.
Publicado em: (1979)

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
por: Preiss, D, et al.
Publicado em: (2013)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
por: Mostafa, SA, et al.
Publicado em: (2017)

FASTING BLOOD-GLUCOSE CONCENTRATIONS AND TREATMENT OF MATURITY-ONSET DIABETES
por: Howedavies, S, et al.
Publicado em: (1980)

Effect of Apple Consumption on Postprandial Blood Glucose Levels in Normal Glucose Tolerance People versus Those with Impaired Glucose Tolerance
por: Yutaka Inoue, et al.
Publicado em: (2022-06-01)

Expert Workshop on Impaired Glucose Tolerance Held in London, UK - 29 March 1995 - Introduction
por: Holman, R
Publicado em: (1996)

Identification of Significant Predictors for the Need of Insulin Therapy and Onset of Postpartum Impaired Glucose Tolerance in Gestational Diabetes Mellitus Patients
por: Wang T, et al.
Publicado em: (2021-06-01)

Comparison of in vivo tests for glucose tolerance in subjects with normal, impaired glucose tolerance and type 2 diabetes
por: Hermans, M, et al.
Publicado em: (1996)

New-onset diabetes after transplantation and oral glucose tolerance test
por: Somsri Wiwanitkit, et al.
Publicado em: (2014-01-01)

The basal plasma glucose: a simple relevant index of maturity-onset diabetes.
por: Holman, R, et al.
Publicado em: (1981)

CONTROL OF MATURITY-ONSET DIABETES BY HOME OR CLINIC MONITORING OF FASTING PLASMA GLUCOSE
por: Howedavies, S, et al.
Publicado em: (1978)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
por: Agbaje, O, et al.
Publicado em: (2017)

Relationship between BMI and risk of impaired glucose tolerance and impaired fasting glucose in Chinese adults: a prospective study
por: Xin Zhang, et al.
Publicado em: (2023-01-01)

Variations in the ghrelin receptor gene associate with obesity and glucose metabolism in individuals with impaired glucose tolerance.
por: Ursula Mager, et al.
Publicado em: (2008-08-01)

Dyslipidemia, metabolic syndrome, and liver enzymes in impaired glucose tolerance and new onset untreated, type 2 diabetes Indian subjects
por: Debmalaya Sanyal, et al.
Publicado em: (2012-01-01)

Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes.
por: McLellan, J, et al.
Publicado em: (1995)

Estimating cardiovascular risk and all-cause mortality in individuals with type 2 diabetes using the UKPDS Outcomes Model
por: Coleman, RL, et al.
Publicado em: (2019)

Machine learning-based models to predict one-year mortality among Chinese older patients with coronary artery disease combined with impaired glucose tolerance or diabetes mellitus
por: Yan Li, et al.
Publicado em: (2023-06-01)

Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years
por: Dahai Yu, et al.
Publicado em: (2023-09-01)